High-risk HPV Does not Appear to be an Important Risk Factor for Sinonasal Carcinomas in Turkish Population: A Tertiary Center Experience


Creative Commons License

Arikan E. A., Aydemir L., Ulusan M., Yilmazbayhan D., Ozluk Y.

INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, cilt.31, sa.2, ss.124-136, 2023 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 31 Sayı: 2
  • Basım Tarihi: 2023
  • Doi Numarası: 10.1177/10668969221091590
  • Dergi Adı: INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED)
  • Sayfa Sayıları: ss.124-136
  • Anahtar Kelimeler: human papillomavirus, sinonasal carcinomas, in situ hybridization, p16, sinonasal papillomas, HUMAN-PAPILLOMAVIRUS HPV, SQUAMOUS-CELL CARCINOMA, INVERTED PAPILLOMA, MALIGNANT-TRANSFORMATION, EGFR-MUTATION, VERRUCOUS CARCINOMA, P53 EXPRESSION, HEAD, INFECTION, CANCER
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background. The sinonasal tract is the second most common site of human papillomavirus (HPV)-related carcinomas in the head and neck. Published data on the association between sinonasal tumors and HPV are quite inconsistent among different regions. Material and methods. We performed high-risk HPV DNA in situ hybridization (ISH) and p16 immunohistochemistry on sinonasal carcinomas diagnosed between 2006 and 2016. Results. Of 105 sinonasal carcinomas, we found only two (2%) HPV-positive cases; both had non-keratinizing morphology and were diffusely positive for p16. By histologic type, HPV DNA positivity rate was 14% in non-keratinizing squamous cell carcinomas, and we did not detect HPV DNA in any other type of sinonasal carcinomas. Thirteen HPV-negative tumors (7 salivary gland carcinomas, 3 sinonasal undifferentiated carcinomas, 2 keratinizing squamous cell carcinomas, and 1 non-keratinizing squamous cell carcinoma) were positive for p16. In nine carcinomas arising from an underlying sinonasal papilloma, p16 and HPV DNA ISH were evaluated in both carcinoma and papilloma areas and all were negative. Follow-up information was available for 104 patients; 46 (44%) were alive and 58 (55%) died of disease. One of the two HPV-positive patients died of the disease; the other was alive at 100 months of follow-up. Conclusions. We detected a much lower percentage of HPV positivity in sinonasal carcinomas when compared to the literature. We believe that our results support various rates of HPV-related carcinomas depending on the geographic and ethnic characteristics.